Menu
GWAS Study

Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.

Cummings AC, Jiang L, Velez Edwards DR et al.

22881374 PubMed ID
GWAS Study Type
798 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CA
Cummings AC
JL
Jiang L
VE
Velez Edwards DR
MJ
McCauley JL
LR
Laux R
ML
McFarland LL
FD
Fuzzell D
KC
Knebusch C
CL
Caywood L
RL
Reinhart-Mercer L
NL
Nations L
GJ
Gilbert JR
KI
Konidari I
TM
Tramontana M
CM
Cuccaro ML
SW
Scott WK
PM
Pericak-Vance MA
HJ
Haines JL
Chapter II

Abstract

Summary of the research findings

To identify novel late-onset Alzheimer disease (LOAD) risk genes, we have analysed Amish populations of Ohio and Indiana. We performed genome-wide SNP linkage and association studies on 798 individuals (109 with LOAD). We tested association using the Modified Quasi-Likelihood Score test and also performed two-point and multipoint linkage analyses. We found that LOAD was significantly associated with APOE (P= 9.0 × 10-6) in all our ascertainment regions except for the Adams County, Indiana, community (P= 0.55). Genome-wide, the most strongly associated SNP was rs12361953 (P= 7.92 × 10-7). A very strong, genome-wide significant multipoint peak [recessive heterogeneity multipoint LOD (HLOD) = 6.14, dominant HLOD = 6.05] was detected on 2p12. Three additional loci with multipoint HLOD scores >3 were detected on 3q26, 9q31 and 18p11. Converging linkage and association results, the most significantly associated SNP under the 2p12 peak was at rs2974151 (P= 1.29 × 10-4). This SNP is located in CTNNA2, which encodes catenin alpha 2, a neuronal-specific catenin known to have function in the developing brain. These results identify CTNNA2 as a novel candidate LOAD gene, and implicate three other regions of the genome as novel LOAD loci. These results underscore the utility of using family-based linkage and association analyses in isolated populations to identify novel loci for traits with complex genetic architecture.

109 Amish cases, 689 Amish controls

Chapter III

Study Statistics

Key metrics and study information

798
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.